Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 5
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
5| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8491932 | TARPEYObudesonide | product | May 2029 |
| 11896719 | TARPEYObudesonide | use | Jan 2043 |
| 12171882 | TARPEYObudesonide | use | Jan 2043 |
| 12171883 | TARPEYObudesonide | product | Jan 2043 |
| 12311057 | TARPEYObudesonide | product | Jan 2043 |
| Product | Exclusivity | Until |
|---|---|---|
| TARPEYOBUDESONIDE | ODE-464 Orphan drug | Dec 2030 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Tarpeyo | budesonide | capsule, delayed release, oral | 81749-004NDA |
Compare
Other companies listing budesonide
- Zydus Lifesciences Limited12 sites · 717 NDC
- L. Perrigo Company3 sites · 243 NDC
- Padagis Israel Pharmaceuticals Ltd2 sites · 236 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- RemedyRepack, Inc1 site · 1,521 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Zydus Pharmaceuticals USA Inc.1 site · 626 NDC
- Cosmo SpA1 site · 4 NDC
- MAJOR Pharmaceuticals Inc.0 sites · 619 NDC
- Northstar Rx, LLC,0 sites · 456 NDC
Enquiry
Common questions
- Is Calliditas Therapeutics AB FDA approved?
- Calliditas Therapeutics AB holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Calliditas Therapeutics AB make?
- 1 product is listed under Calliditas Therapeutics AB in the openFDA NDC Directory, most often as capsule, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.